Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | caspase 3, apoptosis-related cysteine peptidase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cell death protein 3 precursor | caspase 3, apoptosis-related cysteine peptidase | 277 aa | 253 aa | 38.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0034 | 0 | 0.5 |
Onchocerca volvulus | 0.0094 | 0.703 | 1 | |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.012 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Echinococcus multilocularis | caspase 3 | 0.0088 | 0.6288 | 0.6288 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0094 | 0.703 | 0.5 |
Echinococcus granulosus | caspase 3 | 0.0088 | 0.6288 | 0.6288 |
Schistosoma mansoni | brg-1 associated factor | 0.0094 | 0.703 | 0.703 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0034 | 0 | 0.5 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0034 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0094 | 0.703 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Brugia malayi | brahma associated protein 60 kDa | 0.0094 | 0.703 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0094 | 0.703 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.012 | 1 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0094 | 0.703 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0094 | 0.703 | 0.703 |
Loa Loa (eye worm) | brahma associated protein | 0.0094 | 0.703 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0094 | 0.703 | 0.5 |
Echinococcus granulosus | caspase | 0.012 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0094 | 0.703 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0094 | 0.703 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0034 | 0 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0094 | 0.703 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0094 | 0.703 | 0.703 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Echinococcus multilocularis | caspase | 0.012 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0094 | 0.703 | 0.703 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.012 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0094 | 0.703 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0094 | 0.703 | 0.703 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 18.1 uM | Inhibition of human recombinant caspase-3 using Ac-DEVD-AMC as substrate assessed as accumulation of AMC preincubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence assay | ChEMBL. | 23685941 |
IC50 (binding) | = 52.7 uM | Inhibition of human recombinant caspase-7 using Ac-DEVD-AMC as substrate assessed as accumulation of AMC preincubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence assay | ChEMBL. | 23685941 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.